Your browser doesn't support javascript.
loading
Efficient administration of a combination of nifedipine and sildenafil citrate versus only nifedipine on clinical outcomes in women with threatened preterm labor: a systematic review and meta-analysis.
Manouchehri, Elham; Makvandi, Somayeh; Razi, Mahdieh; Sahebari, Maryam; Larki, Mona.
Afiliação
  • Manouchehri E; Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Makvandi S; Department of Midwifery, Faculty of Nursing and Midwifery, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
  • Razi M; Menopause Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Sahebari M; Department of Pediatrics, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Larki M; Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
BMC Pediatr ; 24(1): 106, 2024 Feb 10.
Article em En | MEDLINE | ID: mdl-38341578
ABSTRACT

BACKGROUND:

Preterm labor (PTL) is a common and serious pregnancy disorder that can cause long-term neurological issues in the infant. There are conflicting studies concerning whether sildenafil citrate (SC) reduces preterm labor complications. Therefore, the meta-analysis aimed to examine the clinical outcomes in women with threatened PTL who received nifedipine plus SC therapy versus only nifedipine.

METHODS:

For the original articles, six databases were searched using relevant keywords without restriction on time or language until January 13, 2024. The Cochrane risk-of-bias tool for randomized trials (RoB) and the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) were both used to assess the risk of bias in randomized and non-randomized studies, and GRADE determined the quality of our evidence. Meta-analysis of all data was carried out using Review Manager (RevMan) version 5.1.

RESULTS:

Seven studies with mixed quality were included in the meta-analysis. The study found that combining nifedipine and SC resulted in more prolongation of pregnancy (MD = 6.99, 95% CI 5.32, 8.65, p < 0.00001), a lower rate of delivery in the 1st to 3rd days after hospitalization (RR = 0.62, 95% CI 0.50, 0.76, p < 0.00001), a higher birth weight (252.48 g vs. nifedipine alone, p = 0.02), and the risk ratio of admission to the neonatal intensive care unit (NICU) was significantly lower (RR = 0.62, 95% CI 0.50, 0.76, p < 0.00001) compared to nifidepine alone. The evidence was high for prolongation of pregnancy, delivery rate 24-72 h after admission, and NICU admission, but low for newborn birth weight.

CONCLUSIONS:

Given the effectiveness of SC plus nifedipine in increased prolongation of pregnancy and birth weight, lower delivery in the 1st to 3rd days after hospitalization, and NICU admission, Gynecologists and obstetricians are suggested to consider this strategy for PTL management, although additional article rigor is required to improve the quality of the evidence.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nifedipino / Quimioterapia Combinada / Citrato de Sildenafila / Trabalho de Parto Prematuro Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: BMC Pediatr Assunto da revista: PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nifedipino / Quimioterapia Combinada / Citrato de Sildenafila / Trabalho de Parto Prematuro Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: BMC Pediatr Assunto da revista: PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido